Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial

Background: Lacunar stroke, a frequent clinical manifestation of small vessel disease (SVD), differs pathologically from other ischaemic stroke subtypes and has no specific long-term secondary prevention. Licenced drugs, isosorbide mononitrate (ISMN) and cilostazol, have relevant actions to prevent...

Cijeli opis

Bibliografski detalji

Glavni autori:	Gordon W. Blair, Jason P. Appleton, Katie Flaherty, Fergus Doubal, Nikola Sprigg, Richard Dooley, Carla Richardson, Iona Hamilton, Zhe Kang Law, Yulu Shi, Michael S. Stringer, Michael J. Thrippleton, Julia Boyd, Kirsten Shuler, Philip M. Bath, Joanna M. Wardlaw
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2019-05-01
Serija:	EClinicalMedicine
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2589537019300586
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!